// App-Quantinova.ai

: PHASE 1 RESULTS OF ZUMA-4: KTE-X19, AN ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN PEDIATRIC AND ADOLESCENT PATIENTS WITH RELAPSED/REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Alan S. Wayne

Principal Investigators

  • Van Huynh

  • Nobuko Hijiya

  • Rayne Rouce

  • Patrick A. Brown

  • Joerg Krueger

  • Michael Rytting

  • Carrie L. Kitko

  • Edward Dela Ziga

  • Michelle Hermiston

  • Michael K. Richards

  • Andre Baruchel

  • Tong Shen

  • Lovely Goyal

  • Remus Vezan

  • Rajul Jain

  • Daniel W. Lee

Medical Centers

  • Childrens Hospital Los Angeles, Saban Research Insititute, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA

  • CHOC Children’s Hospital,Orange,United States

  • Ann & Robert H. Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States

  • Texas Childrens Hospital, Houston, TX, United States

  • John Hopkins University, Baltimore, Maryland, United States

  • Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

  • University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • Vanderbilt University, Medical Center, Nashville, United States

  • University of Miami Miller School of Medicine, Miami, FL

  • University of California, San Francisco, United States

  • Children's of Minnesota, Minneapolis, United States

  • Hôpital Universitaire Robert Debré (APHP) and University Paris Diderot,Paris,France

  • Kite, a Gilead company ,Santa Monica,United States

  • University of Virginia, Charlottesville, Virginia, United States

Locations

  • United States

  • Canada

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved